Clinical Research Directory
Browse clinical research sites, groups, and studies.
Local vs Systemic Methotrexate in Management of Uterine Ectopic Pregnancy
Sponsor: Tanta University
Summary
This study aims to compare local and systemic methotrexate in the management of uterine ectopic pregnancy regarding the duration of beta human chorionic gonadotropin (hCG) clearance and need for further management options.
Official title: Local Versus Systemic Methotrexate in Management of Uterine Ectopic Pregnancy: A Randomized Trial
Key Details
Gender
FEMALE
Age Range
20 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
34
Start Date
2024-08-15
Completion Date
2025-07-01
Last Updated
2024-08-16
Healthy Volunteers
No
Interventions
Systemic Methotrexate
Patients will receive systemic methotrexate (intramuscular; 50 mg/m2 body weight).
Local Methotrexate
Patients will receive local methotrexate (25 mg methotrexate as a fixed dose).
Locations (1)
Tanta University
Tanta, El-Gharbia, Egypt